CTOs on the Move

Uroplasty

www.uroplasty.com

 
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

TRS Healthcare

TRS Healthcare is a healthcare staffing company that provides temporary nursing and allied health professionals to facilities across the United States.

Health and Healing

Health and Healing is a Potomac, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dart NeuroScience

At Dart NeuroScience we are visionaries` innovators` and optimists. We are not a typical pharmaceutical company. We are a discovery catalyst` perfectly positioned and structured to make a serious difference in our world. Curious and creative` hopeful and driven – all joined together to fulfill our vision: protect and enhance the quality of mind. With open minds and open hearts` we stretch our limits every day so that we can continue to improve life and the way we live it.

Voyager Therapeutics

Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.

Terumo Cardiovascular Systems Corporation

Terumo Cardiovascular Systems' product line in perfusion circuits is not only one of the most comprehensive in the industry, but also offers an increasing array of products focused on helping surgical teams improve outcomes associated with